Junqing Yang

Publication Activity (10 Years)

Years Active: 2018-2022
Publications (10 Years): 9

Top Topics

Cerebral Ischemia

Mesenchymal Stem Cells

Top Venues

Molecular pharmaceutics

Oxidative medicine and cellular longevity

Fundamental & clinical pharmacology

Molecular biology reports

This page only lists publications with an associated author ORCID identifier.

Publications

Mengyuan Chen, Maozhu Liu, Ying Luo, Jun Cao, Fanning Zeng, Lu Yang, Junqing Yang, Tao Tao, Yu Jiang
Celastrol Protects against Cerebral Ischemia/Reperfusion Injury in Mice by Inhibiting Glycolysis through Targeting HIF-1 α /PDK1 Axis. Oxidative medicine and cellular longevity 2022 (2022)
Pu Xiang, Jian Hu, Hong Wang, Ying Luo, Chao Gu, Xiaodan Tan, Yujun Tu, Wenjia Guo, Lin Chen, Lin Gao, Rongchun Chen, Junqing Yang
miR-204-5p is sponged by TUG1 to aggravate neuron damage induced by focal cerebral ischemia and reperfusion injury through upregulating COX2. Cell death discovery 8 (1) (2022)
Wen Luo, Junqing Yang
Schizophrenia predisposition gene Unc-51-like kinase 4 for the improvement of cerebral ischemia/reperfusion injury. Molecular biology reports 49 (4) (2022)
Yuke Li, Wen Luo, Jiahua Zhang, Ying Luo, Wenli Han, Hong Wang, Hui Xia, Zhihao Chen, Yang Yang, Qi Chen, Huan Li, Lu Yang, Congli Hu, Haifeng Huang, Zhe Peng, Xiaodan Tan, Miaomiao Li, Junqing Yang
Maternal Inflammation Exaggerates Offspring Susceptibility to Cerebral Ischemia-Reperfusion Injury via the COX-2/PGD2/DP 2 Pathway Activation. Oxidative medicine and cellular longevity 2022 (2022)
Miaomiao Li, Junqing Yang, Oumei Cheng, Zhe Peng, Yin Luo, Dongzhi Ran, Yang Yang, Pu Xiang, Haifeng Huang, Xiaodan Tan, Hong Wang
Effect of TO901317 on GF to promote the differentiation of human bone marrow mesenchymal stem cells into dopamine neurons on Parkinson's disease. Therapeutic advances in chronic disease 12 (2021)
Hui Xia, Qin He, Hong Wang, Yongming Wang, Yang Yang, Yuke Li, Jiahua Zhang, Zhihao Chen, Junqing Yang
Treatment with either COX-2 inhibitor or 5-LOX inhibitor causes no compensation between COX-2 pathway and 5-LOX pathway in chronic aluminum overload-induced liver injury in rats. Fundamental & clinical pharmacology 33 (5) (2019)
Congli Hu, Junqing Yang, Qin He, Ying Luo, Zhihao Chen, Lu Yang, Honggang Yi, Huan Li, Hui Xia, Dongzhi Ran, Yang Yang, Jiahua Zhang, Yuke Li, Hong Wang
CysLTR1 Blockage Ameliorates Liver Injury Caused by Aluminum-Overload via PI3K/AKT/mTOR-Mediated Autophagy Activation in Vivo and in Vitro. Molecular pharmaceutics 15 (5) (2018)
Huan Li, Ying Luo, Ying Xu, Lu Yang, Congli Hu, Qi Chen, Yang Yang, Jie Ma, Jiahua Zhang, Hui Xia, Yuke Li, Junqing Yang
Meloxicam Improves Cognitive Impairment of Diabetic Rats through COX2-PGE2-EPs-cAMP/pPKA Pathway. Molecular pharmaceutics 15 (9) (2018)
Shaoshan Mai, Lin Zou, Xiaoyan Tian, Xiao Liao, Yizhao Luan, Xing Han, Yuling Wei, Yue Wu, Shengnan Kuang, Yang Yang, Jie Ma, Qi Chen, Junqing Yang
Double-Edged Effect of Hydroxychloroquine on Human Umbilical Cord-Derived Mesenchymal Stem Cells Treating Lupus Nephritis in MRL/lpr Mice. Molecular pharmaceutics 15 (5) (2018)